|
1
|
In vivo amplification of the androgen receptor gene and progression of human prostate cancer.
|
Nat Genet
|
1995
|
6.60
|
|
2
|
Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization.
|
Cancer Res
|
1995
|
3.98
|
|
3
|
Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer.
|
Cancer Res
|
1997
|
3.37
|
|
4
|
Evidence for a prostate cancer susceptibility locus on the X chromosome.
|
Nat Genet
|
1998
|
2.90
|
|
5
|
Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.
|
J Clin Oncol
|
1999
|
2.45
|
|
6
|
The story of the European Randomized Study of Screening for Prostate Cancer.
|
BJU Int
|
2003
|
1.55
|
|
7
|
Postoperative urinary retention. I. Incidence and predisposing factors.
|
Scand J Urol Nephrol
|
1986
|
1.29
|
|
8
|
Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years.
|
Urology
|
1998
|
1.16
|
|
9
|
A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
|
Clin Cancer Res
|
2000
|
1.16
|
|
10
|
A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer.
|
Eur Urol
|
1998
|
1.13
|
|
11
|
European randomized study of prostate cancer screening: first-year results of the Finnish trial.
|
Br J Cancer
|
1999
|
1.09
|
|
12
|
Biodegradable self-reinforced polyglycolic acid spiral stent in prevention of postoperative urinary retention after visual laser ablation of the prostate-laser prostatectomy.
|
J Urol
|
1995
|
1.02
|
|
13
|
Postoperative urinary retention. II. Micturition problems after the first catheterization.
|
Scand J Urol Nephrol
|
1986
|
1.01
|
|
14
|
Immunodetection of androgen receptor in human urinary bladder cancer.
|
Histopathology
|
1997
|
0.95
|
|
15
|
A randomized study to compare biodegradable self-reinforced polyglycolic acid spiral stents to suprapubic and indwelling catheters after visual laser ablation of the prostate.
|
J Urol
|
1997
|
0.94
|
|
16
|
Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen.
|
J Clin Endocrinol Metab
|
2000
|
0.93
|
|
17
|
Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the Finnish Prostate Cancer Group.
|
Eur J Cancer
|
1993
|
0.92
|
|
18
|
Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate.
|
J Steroid Biochem Mol Biol
|
1998
|
0.90
|
|
19
|
Analysis of genetic changes underlying local recurrence of prostate carcinoma during androgen deprivation therapy.
|
Am J Pathol
|
1995
|
0.89
|
|
20
|
Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer.
|
Int Urol Nephrol
|
1992
|
0.88
|
|
21
|
Prevention of prolonged voiding problems after unexpected postoperative urinary retention: comparison of phenoxybenzamine and carbachol.
|
J Urol
|
1986
|
0.88
|
|
22
|
Androgen receptor gene amplification in a recurrent prostate cancer after monotherapy with the nonsteroidal potent antiandrogen Casodex (bicalutamide) with a subsequent favorable response to maximal androgen blockade.
|
Eur Urol
|
1997
|
0.86
|
|
23
|
Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine.
|
Drugs Aging
|
2001
|
0.83
|
|
24
|
Efficacy and safety of clean intermittent catheterization in adults.
|
Eur Urol
|
1991
|
0.80
|
|
25
|
Bioabsorbable and biodegradable stents in urology.
|
J Endourol
|
1997
|
0.79
|
|
26
|
Aetiology of priapism in 207 patients.
|
Eur Urol
|
1995
|
0.79
|
|
27
|
Erectile dysfunction as a risk factor for coronary heart disease: implications for prevention.
|
Int J Clin Pract
|
2007
|
0.79
|
|
28
|
Three-year results of the Finnish prostate cancer screening trial.
|
J Natl Cancer Inst
|
2001
|
0.79
|
|
29
|
The effects of combination therapy with dutasteride plus tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year post hoc analysis of European men in the CombAT study.
|
Prostate Cancer Prostatic Dis
|
2011
|
0.78
|
|
30
|
Screening for prostate cancer using serum prostate-specific antigen: a randomised, population-based pilot study in Finland.
|
Br J Cancer
|
1996
|
0.77
|
|
31
|
High cell proliferation activity determined by DNA flow cytometry predicts poor prognosis after relapse in prostate cancer.
|
Eur J Cancer
|
1994
|
0.77
|
|
32
|
Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.
|
Ann Chir Gynaecol
|
2001
|
0.76
|
|
33
|
Immunohistochemical localization of carbonic anhydrase isoenzymes in the human male reproductive tract.
|
Histochemistry
|
1990
|
0.75
|
|
34
|
[Management of scrotal hydrocele by sclerotherapy].
|
Duodecim
|
1988
|
0.75
|
|
35
|
Antibiotic prophylaxis in patients with urinary retention undergoing transurethral prostatectomy.
|
Ann Chir Gynaecol
|
1997
|
0.75
|
|
36
|
[Urethral carcinoma in men--a difficult diagnostic problem].
|
Duodecim
|
1989
|
0.75
|
|
37
|
[Male sexual dysfunction].
|
Duodecim
|
2001
|
0.75
|
|
38
|
Intravesical prostaglandin F2 for promoting bladder emptying after surgery for female stress incontinence.
|
Br J Urol
|
1987
|
0.75
|
|
39
|
[When is an andrologist needed?].
|
Duodecim
|
2001
|
0.75
|
|
40
|
Intravesical epirubicin with and without verapamil for the prophylaxis of superficial bladder tumours.
|
Scand J Urol Nephrol
|
1991
|
0.75
|
|
41
|
[Surgical management of impotence].
|
Duodecim
|
1988
|
0.75
|
|
42
|
[Management of urinary incontinence by an internal prosthesis].
|
Duodecim
|
1988
|
0.75
|
|
43
|
Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer.
|
J Urol
|
2001
|
0.75
|
|
44
|
[About Psa-screening].
|
Duodecim
|
1996
|
0.75
|
|
45
|
The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
|
Ann Chir Gynaecol
|
2001
|
0.75
|
|
46
|
Ethanolamine oleate as a sclerosant for testicular hydroceles and epididymal cysts.
|
Br J Urol
|
1988
|
0.75
|
|
47
|
[Ultrasonic confirmation of scrotal pathology].
|
Duodecim
|
1989
|
0.75
|
|
48
|
[Treatments of benign prostatic hypertrophy and their cost-benefit relationship].
|
Duodecim
|
2000
|
0.75
|
|
49
|
Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancer.
|
Eur Urol
|
1988
|
0.75
|
|
50
|
Efficacy and safety of bladder neck incision in patients with benign prostatic hyperplasia.
|
Ann Chir Gynaecol Suppl
|
1993
|
0.75
|
|
51
|
[Prostaglandin management of urine retention after surgery for incon- tinence].
|
Duodecim
|
1988
|
0.75
|
|
52
|
Prospective randomized open study between ciprofloxacin and a combination of sulfadiazine and trimethoprim in antibiotic prophylaxis in connection with transurethral prostatectomy.
|
Scand J Urol Nephrol
|
1996
|
0.75
|
|
53
|
[Why screen for prostate cancer in Finland?].
|
Duodecim
|
1996
|
0.75
|
|
54
|
Reduction of flutamide-induced alanine aminotransferase elevation after replacement by bicalutamide in a patient with N+ disease treated with maximal androgen blockade as a primary treatment.
|
Br J Urol
|
1997
|
0.75
|
|
55
|
Ranitidine versus anticholinergic/antacid for duodenal ulcer. A randomized, endoscopically controlled, single-blind multicentre trial.
|
Scand J Gastroenterol
|
1985
|
0.75
|